Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||EP9605 / UNK||- / -|
Administered by: Other Purchased by: ??
Symptoms: Sudden death
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Other Medications: ASAFLOW; INEGY; LISINOPRIL; SINTROM; TARDYFERON; TENORMIN
Preexisting Conditions: Medical History/Concurrent Conditions: Angioplasty (angioplasty stenting); Ischemic heart disease; Myocardial necrosis (patient with a history of antero-septal myocardial necrosis); Thrombocytopenia
Diagnostic Lab Data:
CDC 'Split Type': BEPFIZER INC2021398715
Write-up: Sudden death during an effortless walk this 26mar2021 after the vaccine no adverse effects before, no complaints before the walk; This is as spontaneous report received from a contactable physician downloaded from the Regulatory Authority-WEB. The regulatory authority report number BE-FAMHP-DHH-N2021-86449. A 72-year-old male patient received bnt162b2 (COMIRNATY, Lot Number: EP9605), via an unspecified route of administration on 23Mar2021 13:30 as single dose for COVID-19 immunization. Medical history included ischemic heart disease, antero-septal myocardial necrosis, angioplasty stenting, and stable isolated thrombocytopenia, all from an unknown date. Concomitant medications included acetylsalicylic acid (ASAFLOW), ezetimibe, simvastatin (INEGY), lisinopril, acenocoumarol (SINTROM), ferrous sulfate (TARDYFERON), and atenolol (TENORMIN) all taken for an unspecified indication, start and stop date were not reported. The patient experienced sudden death during an effortless walk this 26Mar2021 after the vaccine no adverse effects before, no complaints before the walk. The patient died on 26Mar2021. It was not reported if an autopsy was performed. Reporter comment: Treatment - Evolution of the ADR - Death. Relatedness of drug to reaction(s)/event(s): Source of assessment: Health Agency. Method of assessment: WHO. Result of Assessment : unclassifiable. No follow-up attempts are possible. No further information is expected.; Reporter''s Comments: Treatment - Evolution of the ADR - Death. Relatedness of drug to reaction(s)/event(s): Source of assessment: Health Agency. Method of assessment: WHO. Result of Assessment : unclassifiable.; Reported Cause(s) of Death: sudden death
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166